OptimizeRx Profit Margin

The latest profit margin for OPRX is 4.66% as of June 2026. That compares with -9.42% in the prior-year period — up 149.5% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside OptimizeRx's historical trend and sector peers before judging valuation or financial health.

Over the past year, OPRX's profit margin moved from -9.42% to 4.66% — a 149.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in OptimizeRx's valuation or profitability profile.

Against Healthcare companies, OPRX currently prints 4.66% for profit margin, while the sector average sits near 13.89%. That is roughly 66.4% below the sector mean. Large gaps often invite a closer look at OptimizeRx's growth, margins, and balance sheet.

Profit Margin shows how effectively OptimizeRx converts resources into returns. At 4.66%, OPRX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -9.42% in the prior-year period — up 149.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting OPRX's profit margin (4.66%), review year-over-year change from -9.42%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.